The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The Ro Body Program offers eligible individuals access to Wegovy, as well as Ozempic and Zepbound, after consulting with ... into each brand’s reputation before sharing products and services ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

Always speak with your doctor before starting any new supplement or exercise regimen ... Seltzer and Nastasi agree most ...

Few things have stirred up as much commotion in either the weight loss or pharmaceutical world as Ozempic and Wegovy ... of 14.9% of their body weight after 68 weeks, compared with an average ...

GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...

The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring ...

Novo Nordisk A/S’s sales of the blockbuster weight-loss drug Wegovy leapt last quarter as it became available in more ...

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year ...

You may have to meet a higher deductible before having weight loss drugs covered because they're often included in your medical benefits, instead of being a prescription benefit. After initial ...